Welcome to the Razadyne ER web site.
In order to view this web site correctly you will need to upgrade your version of Flash Player.
There have been reports of name confusion between RAZADYNE ® , our treatment for the symptoms of mild to moderate Alzheimer’s disease and ROZEREM, a medication for the treatment of insomnia, marketed by Takeda Pharmaceuticals America, Inc. Click here to learn more.
RAZADYNE ®ER is used to treat the symptoms of mild to moderate Alzheimer's disease such as memory loss
IMPORTANT SAFETY INFORMATION
In clinical trials, the most frequent adverse events with RAZADYNE ® ER were similar to the twice-daily formulation of galantamine HBr. With the twice-daily formulation of galantamine HBr, the most common side effects were nausea, vomiting, diarrhea, loss of appetite, and weight loss. Typically these side effects were mild and temporary.
RAZADYNE ® ER may not be for everyone. Some people experience a slowed heart rate, which may lead to fainting. Serious stomach problems can occur in people taking medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) or those at risk for stomach ulcers.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
For more information, read the full US Prescribing Information by clicking here.
ROZEREM™ is a registered trademark of Takeda Pharmaceutical and used under license by Takeda Pharmaceuticals America, Inc.
Privacy Policy | Full Prescribing Information | Legal Notice | Contact Us | Janssen Pharmaceuticals, Inc.
This page was last updated on: Apr 01 2010 at 09:40:03 EDT